This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing C-Kit targeting for CSU (chronic spontaneous urticaria), PN (prurigo nodularis, EOE (eosinophilic esophagitis), aSM (advanced systemic mastocytosis), and iSM (indolent systemic mastocytosis)

Ticker(s): CLDX, JSPR, BPMC, COGT

Who's the expert?

Institution: Charité Universitätsmedizin in Berlin

  • Professor of Dermatology and Allergy and Director of Research at the Department of Dermatology and Allergy, Allergie-Centrum-Charité of the Charité - Universitätsmedizin in Berlin.
  • Coordinator of the GA²LEN urticaria centers of reference and excellence (UCARE) network & Coordinator of the National Priority Programme “Physiological functions of mast cells”. 
  • Has published >557 publications in peer-review journals and 40 books and book chapters.

Interview Goal
Discussing C-Kit as a MOA in various indications

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.